Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CL2020 Muse cell therapy in adults with epidermolysis bullosa
jRCT1080224498Phase 2Completed
- Sponsor
- Life Science Institute
- Start
- Dec 2018
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of CL2020 in epidermolysis bullosa (EB), sponsored by Life Science Institute. Started Dec 2018; status: completed.
02
Drugs
CL2020
03
Conditions
epidermolysis bullosa (EB)
Beyond the preview
Go deeper on jRCT1080224498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224498.